-
Something wrong with this record ?
In vitro comparison of the effectiveness of various antimicrobial locks with taurolidine in the treatment and prevention of catheter-related bloodstream infections in patients receiving parenteral nutrition
J. Visek, L. Ryskova, A. Machacova, M. Marikova, V. Blaha
Language English Country United States
Document type Journal Article
NLK
ProQuest Central
from 2003-01-01 to 2 months ago
Nursing & Allied Health Database (ProQuest)
from 2003-01-01 to 2 months ago
Health & Medicine (ProQuest)
from 2003-01-01 to 2 months ago
Health Management Database (ProQuest)
from 2003-01-01 to 2 months ago
Public Health Database (ProQuest)
from 2003-01-01 to 2 months ago
- MeSH
- Anti-Infective Agents * pharmacology therapeutic use MeSH
- Catheter-Related Infections * drug therapy prevention & control MeSH
- Catheters adverse effects MeSH
- Humans MeSH
- Methicillin-Resistant Staphylococcus aureus * MeSH
- Parenteral Nutrition adverse effects MeSH
- Sepsis * complications MeSH
- Staphylococcus aureus MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: To evaluate the effectiveness of various taurolidine solutions in the prevention and treatment of catheter-related bloodstream infections (CRBSIs) caused by the entire spectrum of microbes in patients receiving parenteral nutrition in a shorter period of time. METHODS: The in vitro method was used to test for eradication of biofilm. Different locks were used: TauroSept (2%), TauroLock (1.35%), TauroLock half concentration, and 3.5% taurolidine and tested on Staphylococcus (S.) epidermidis, S. aureus, S. hominis, methicillin-resistant S. aureus (MRSA), Pseudomonas (P.) aeruginosa (PSAE), multidrug-resistant P. aeruginosa (MR PSAE), vancomycin-resistant enterococci, Klebsiella pneumoniae producing carbapenemase (KPC), Klebsiella pneumoniae producing extended-spectrum beta-lactamase (KLPN ESBL), Candida (C.) albicans, and C. glabrata. Broviac catheters were incubated for growth of each organism and then incubated in lock solutions. Colony forming units (CFUs) were then counted after 30 min, 60 min, and 120 min of incubation. RESULTS: A statistically significant decrease in CFUs was observed after 30 min of taurolidine exposure for S. hominis, PSAE, KLPN ESBL, KLPN KPC, C. albicans, and C. glabrata; after 60 min of exposure for S. epidermidis, PSAE, MR PSAE, KLPN ESBL, KPC, C. albicans, and C. glabrata; and after 120 min of exposure for S. epidermidis, S. hominis, S. aureus, PSAE, MR PSAE, KLPN ESBL, KPC, C. albicans, C. glabrata. CONCLUSIONS: The application of taurolidine is effective in the treatment of CRBSIs. Taurolidine proved to be more effective against Gram-negative microorganisms during a 30-min exposure. Using 0.675% taurolidine is still effective. To achieve the required antimicrobial effect, the catheter must be sanitized for at least 2 h.
Department of Clinical Pharmacy Regional Hospital Trutnov Trutnov Czech Republic
Integrity Nutraceuticals International Spring Hill Tennessee USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016130
- 003
- CZ-PrNML
- 005
- 20231026110338.0
- 007
- ta
- 008
- 231013s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.nut.2023.112115 $2 doi
- 035 __
- $a (PubMed)37450960
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Visek, Jakub $u Department of Gerontology and Metabolism, University Hospital and Medical Faculty in Hradec Kralove, Charles University in Prague, Czech Republic. Electronic address: visekjak@fnhk.cz
- 245 10
- $a In vitro comparison of the effectiveness of various antimicrobial locks with taurolidine in the treatment and prevention of catheter-related bloodstream infections in patients receiving parenteral nutrition / $c J. Visek, L. Ryskova, A. Machacova, M. Marikova, V. Blaha
- 520 9_
- $a OBJECTIVES: To evaluate the effectiveness of various taurolidine solutions in the prevention and treatment of catheter-related bloodstream infections (CRBSIs) caused by the entire spectrum of microbes in patients receiving parenteral nutrition in a shorter period of time. METHODS: The in vitro method was used to test for eradication of biofilm. Different locks were used: TauroSept (2%), TauroLock (1.35%), TauroLock half concentration, and 3.5% taurolidine and tested on Staphylococcus (S.) epidermidis, S. aureus, S. hominis, methicillin-resistant S. aureus (MRSA), Pseudomonas (P.) aeruginosa (PSAE), multidrug-resistant P. aeruginosa (MR PSAE), vancomycin-resistant enterococci, Klebsiella pneumoniae producing carbapenemase (KPC), Klebsiella pneumoniae producing extended-spectrum beta-lactamase (KLPN ESBL), Candida (C.) albicans, and C. glabrata. Broviac catheters were incubated for growth of each organism and then incubated in lock solutions. Colony forming units (CFUs) were then counted after 30 min, 60 min, and 120 min of incubation. RESULTS: A statistically significant decrease in CFUs was observed after 30 min of taurolidine exposure for S. hominis, PSAE, KLPN ESBL, KLPN KPC, C. albicans, and C. glabrata; after 60 min of exposure for S. epidermidis, PSAE, MR PSAE, KLPN ESBL, KPC, C. albicans, and C. glabrata; and after 120 min of exposure for S. epidermidis, S. hominis, S. aureus, PSAE, MR PSAE, KLPN ESBL, KPC, C. albicans, C. glabrata. CONCLUSIONS: The application of taurolidine is effective in the treatment of CRBSIs. Taurolidine proved to be more effective against Gram-negative microorganisms during a 30-min exposure. Using 0.675% taurolidine is still effective. To achieve the required antimicrobial effect, the catheter must be sanitized for at least 2 h.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Staphylococcus aureus $7 D013211
- 650 12
- $a methicilin rezistentní Staphylococcus aureus $7 D055624
- 650 12
- $a katétrové infekce $x farmakoterapie $x prevence a kontrola $7 D055499
- 650 12
- $a antiinfekční látky $x farmakologie $x terapeutické užití $7 D000890
- 650 _2
- $a katétry $x škodlivé účinky $7 D057785
- 650 _2
- $a parenterální výživa $x škodlivé účinky $7 D010288
- 650 12
- $a sepse $x komplikace $7 D018805
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ryskova, Lenka $u Department of Clinical Microbiology, University Hospital and Medical Faculty in Hradec Kralove, Charles University in Prague, Czech Republic
- 700 1_
- $a Machacova, Alena $u Department of Clinical Microbiology, University Hospital and Medical Faculty in Hradec Kralove, Charles University in Prague, Czech Republic
- 700 1_
- $a Marikova, Martina $u Department of Clinical Pharmacy, Regional Hospital Trutnov, Trutnov, Czech Republic; Department of Social and Clinical Pharmacy, Charles University, Faculty of Pharmacy in Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Blaha, Vladimir $u Department of Gerontology and Metabolism, University Hospital and Medical Faculty in Hradec Kralove, Charles University in Prague, Czech Republic; Integrity Nutraceuticals International, Spring Hill, Tennessee, USA
- 773 0_
- $w MED00003566 $t Nutrition (Burbank, Los Angeles County, Calif.) $x 1873-1244 $g Roč. 114, č. - (2023), s. 112115
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37450960 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026110331 $b ABA008
- 999 __
- $a ok $b bmc $g 1999947 $s 1202492
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 114 $c - $d 112115 $e 20230604 $i 1873-1244 $m Nutrition $n Nutrition $x MED00003566
- LZP __
- $a Pubmed-20231013
